Theranos faces congressional inquiry over faulty blood tests

The U.S. House of Representatives recently sent a letter to troubled blood analysis startup Theranos asking for an explanation of the company’s failure to offer accurate results to patients using its proprietary blood test technology. Theranos developed a technique using its proprietary ‘Edison’ machine it claimed could detect hundreds of diseases using just one drop of blood. Read More...